Fenipic Plus
Fenipic Plus is a medicine authorised by Swissmedic under authorisation number 60810. The authorisation holder is Haleon Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 09 December 2009 and the authorisation is valid without a time limit. ATC code D04AX places the medicine in the group Antipruritics.
| Authorisation number | 60810 |
|---|---|
| Name | Fenipic Plus |
| Full name | Fenipic Plus, Lösung zur Anwendung auf der Haut |
| Authorisation holder | Haleon Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | D04AX |
| First authorisation | 09 December 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fenipic Plus, Lösung zur Anwendung auf der Haut | D | 09 December 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 8 | ml | D04AX | 10.01.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fenipic Plus authorised in Switzerland?
Yes. Fenipic Plus is authorised by Swissmedic under authorisation number 60810, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Fenipic Plus have?
Fenipic Plus is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Fenipic Plus?
The authorisation holder is Haleon Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.